DOTA-cyclo (RGDfK)
DOTA-cyclo (RGDfK) is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].
Product Specifications
CAS Number
909024-55-1
UNSPSC
12352005
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dota-cyclo-rgdfk.html
Purity
98.10
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N1)=O)CC(O)=O)=O)=O)CCCNC(N)=N)=O)CCCCNC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)[C@H]1CC3=CC=CC=C3
Molecular Formula
C43H67N13O14
Molecular Weight
990.07
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470296-500 1x 500 µL
Blood Group Antigen B (CD173) (HEB-20), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
